Friday, June 26, 2009
Sorry about the extra post, but....
The Center to Advance Palliative Care (CAPC) is circulating a petition (originating from the American Pain Foundation) to urge the FDA to protect the rights of people with pain regarding access to opioids, as the REMS process unfolds.
The text of their press release/call to action:
As you are probably aware by now, the U.S. Food & Drug Administration (FDA) is currently working with makers of long-acting opioids to develop a plan to reduce opioid diversion/illicit use. This plan is known as Risk Evaluation and Mitigation Strategies, or REMS. The FDA is currently accepting comments from the general public until June 30, 2009 surrounding this issue. You should know that some of the comments the FDA has received have called for an outright ban or moratorium on certain opioid pain medications.
CAPC is distributing a petition created by the American Pain Foundation in order to help facilitate your response to the FDA. Please sign this petition TODAY to help make sure that patients in pain continue to have access to effective pain care, including prescribed opioid medications. Your voice and the voices of other pain advocates are needed to remind decision makers that the lives and livelihoods lost to pain are worth no less than victims of drug misuse or abuse. The FDA needs to hear how vital access to these medications is to people with pain and what tragic results could occur if they were denied access to these medications or if additional barriers were created making access more difficult for people who are legitimately prescribed these medications.
CAPC page about FDA action/REMS here.
Friday, June 26, 2009 by Drew Rosielle MD ·
Thursday, June 25, 2009
Lancet has an editorial about euthanasia (by a palliative doc and UK Member of Parliament**) and the shift in the UK debate about euthanasia from 'relief of suffering' to 'patient choice/control.'
It begins provocatively:
The rest of the editorial discusses a renewed focus within the UK debate on choice/control. It's an issue we've discussed before on the blog, and in some ways reflects, at least in my opinion, a focusing of the debate onto the issues that most drive requests for/interest in assisted death (assisted suicide and euthanasia) where it is practiced: it is not actually used as a last resort option in patients suffering intractably (at least physically). Palliative/terminal sedation (let's leave aside debate about what term to actually use) is used in these scenarios (generally speaking - even in the Netherlands where both TS and AD are practiced it seems TS is generally used to treat active/current intractable physical symptoms like pain, dyspnea, restlessness). Assisted death, generally, is sought by those who wish to control the circumstances of their death, and are worried about future indignity, loss of meaning, and symptoms.
“I have never seen such a clear cut case for euthanasia” were the general practitioner's words when he referred to me a young man with a fungating malignant spinal tumour. The patient's distress was palpable and compounded by neuropathic pain. But, most of all, he hated losing control through creeping paraplegia and through his increasing dependence on his young wife, who was struggling to cope with their two children and 7-week-old baby. He asked me to end it for him, and his request persisted for several weeks. He would have passed all the tests about mental competence that euthanasia campaigners suggest and appeared to fulfil all the criteria in legislation from other countries: he was terminally ill with a short predicted prognosis, suffering unbearably, persistent in his competent request, fully informed, and had no psychiatric condition.
That was 1991. In 2001, he telephoned me to say that his beautiful wife had been diagnosed with pancreatic cancer. She died some months later, and he has brought up their children alone, aware that the law in Britain had saved them from being orphaned. Yet the media campaign for legalising what is euphemistically called “assisted dying” rarely shows this side of the coin.
So actually framing the debate this way seems to me to be, at the very least, honest, and for it or against it I think it is appropriate to at least have the discussion about assisted death in the context that in real life it is not generally used for the relief of active (somatic) suffering but for more existential reasons around loss, control, etc. To rephrase: the actual debate about it should less be about whether it is necessary to have access to euthanasia as a way to 'treat' intractable suffering and more about patients' rights to have medically-assisted deliberate hastening of death for (the complex of interrelated concerns around control/loss/dignity that I'll paraphrase as) 'existential' reasons.
While absolutely acknowledging that this is indeed why most patients seek assisted death, the author is concerned this shift in the rhetoric/justification for euthanasia/assisted death is tied with a (what she states is at least for some an intentional) de-linking of assisted death from terminal illness itself. And, apparently, this is happening. She discusses some draft proposals being tossed around in the Scottish Parliament:
Her consultation document, intended as a prelude to a bill in the Scottish Parliament, proposes to legalise euthanasia not only for people who are terminally ill but also for others “enjoying otherwise satisfactory health but with degenerative, irreversible conditions”, for “patients who unexpectedly become incapacitated to a degree they find intolerable”, and to people “who are not terminally ill, suffering from a degenerative condition, or unexpectedly incapacitated but who find their life to be intolerable”. These wide-ranging proposals seem a natural consequence of the shift in emphasis of the pro-euthanasia campaign from the relief of pain and other symptomatic distress in the dying to an agenda based on personal choice and control.I have written on the blog before that I'm essentially against the legalization of 'assisted death' practices (physician assisted suicide and euthanasia) as for me I do not think that loss of meaning/choice/control are sufficient reasons to have medical assistance with dying. I understand why people (at least a substantial minority if not a majority of Americans) are for the legalization of assisted suicide. One of the leading proponents of its legalization once told me that we can say all we want about the effectiveness of palliative care and, if needed, palliative/terminal sedation, but many patients just don't trust us to be there for them. I also think about what my patients go through sometimes and ask myself 'Yikes, would I really go through that myself?'
For me, thouth, it's about the role of medicine in these scenarios - is this loss of meaning (or however you want to describe the existential issues at play here) and desire for control the domain of medicine or not? Something which should be 'treated' medically? I basically come down on the side of 'No.' Acknowledging that I do treat this 'medically' all the time of course, with antidepressants for 'depression' even at times when I suspect it's not this organic brain disease called 'depression' but Something Else; or with benzodiazepines for 'anxiety,' etc. This is perhaps hypocritical, and makes me wonder if I've decided that it's not that it shouldn't be medicalized, but that it shouldn't be medicalized 'in that way' so to speak.
Regardless of this, I do think it's possible to have this debate and not de-link assisted death with terminal illness. I accept that this delinking is happening but don't think it is inevitable....
These issues aren't going away, and am interested in what others have to say about this.
**Sounds like a good combo to me and something we should try stateside. Hmmmm...Diane Meier?
Thursday, June 25, 2009 by Drew Rosielle MD ·
Briefly - this week's NEJM has a report about hospice trends (free full-text here), focusing on issues to do with extended hospice lengths of stay, payment, and concerns that for-profit hospices are gaming the system a little (that language is not used, but implied). It doesn't directly mention 'hospice cap' issues but clearly those issues are relevant to the article. Mostly it summarizes MedPAC's recent recommendations and the impact implementing them could have on hospices.
The increasing proportion of lengths of stay exceeding 180 days and the variability in length of stay among hospices also convinced MedPAC that Medicare should change the manner in which patients are recertified for eligibility. After being deemed eligible by two physicians, one of whom is the hospice medical director, beneficiaries elect hospice care for defined periods, the first of which is 90 days. After a second 90-day period, patients can be recertified for an unlimited number of 60-day periods if their life expectancy remains 6 months or less. But after initial approval, recertification falls solely within the purview of the hospice's medical director, not the patient's physician. In an effort to improve adherence to the coverage criteria in determining eligibility, MedPAC has recommended requiring documented physician oversight as well as additional medical review of long stays at hospices with a disproportionate number of such stays — to "identify providers with inappropriate admissions or recertification practices."MedPAC also recommended that the Office of Inspector General investigate the prevalence of financial relationships between hospices and long-term care facilities "that may represent a conflict of interest and influence admissions to hospice" and examine the enrollment practices of hospices with patterns of unusually long or short stays.
by Drew Rosielle MD ·
Tuesday, June 23, 2009
Journal of Medical Ethics has an article about hospitalized patients' understanding of and attitudes towards code status discussions (see also this blog post about a similar study). The study involved interviewing ~140 newly hospitalized patients (median age 48 years, 92% white, over 80% had were expected to live more than 2 years according to their treating physician) about their understanding of and attitudes toward CPR, code status orders, etc. Among other things they were asked what they thought the survival was for in-hospital arrests; they were then told it was about 15% survival to discharge and were asked if that changed their preferences for wanting CPR, etc.
Patients had very poor understanding of CPR and its outcomes. About 30% of patients recalled having a discussion about code status during the hospitalization. Most patients noted that they thought they knew what CPR meant and entailed. 68% knew it meant chest compressions however only 27% knew it could involve defibrillation and only 7% mechanical ventilation. About 90% of patients (including the oldest group) said they would want all 3 (of note when they describe the situation they describe it as one in which 'you are dying').
Overall patients estimated survival to discharge after an in-hospital arrest to be 60%. After being told actual expected survival is about 15%, 9 patients said they were less interested in CPR. After being told expected survival to discharge with 'good brain function' was about 7%, 25 patients said they were less interested in receiving CPR.
8% of patients had code statuses which did not reflect their stated preferences; 2/3 of whom were 'full code' and didn't want to be. They noted that over 80% of patients said they thought it was good to talk about CPR outcomes. Only a few percent said talking about CPR made them uncomfortable. About a quarter of patients said they had living wills/advance directives; less than 5% of patients had them in their chart.
While they did collect data about physician estimation of prognosis, they do not mention if they compared that with patient preferences or anything else.
This is another solid reminder of how little patients actually understand about CPR - both its 'methods' and outcomes, and that we should take nothing for granted when discussing it. It also indicates that discussion of outcomes does change some patients minds, although a relatively small percent overall (fewer than this landmark study, although that one involved a much older patient population, and asked questions in the context of a patient's long-term survival as well). The fact that these were young and relatively 'healthy' patients probably is what leads to these results, especially compared to the older study: if you are 48 years old, expecting another 20-40 years of life, a 15% chance sounds pretty good. If you have a progressive, life-limiting disease, with a short overall survival (e.g. likely less than a year) the benefit:burden profile looks much different (aside from the reality that in those patients 15% is probably a generous figure).
Tuesday, June 23, 2009 by Drew Rosielle MD ·
Saturday, June 20, 2009
The article further describes the tension between allopathic medicine and the program. One of the chaplains talks of "culture change" they hope to bring to medicine but later also discusses his hope that their methods might lend to the endpoints with which physicians are concerned (e.g. one suggests that alternative therapies may improve adherence to a diabetic regimen rather than providing a competitive alternative that detracts from the regimen's benefit). A physician who cares for the patient remains unconvinced.
Certainly, I could envision some of the tension described in the article, especially if there are circumstances when chaplains might recommend to non-compliant patients to pursue alternative "disease modifying" therapies versus medically proven treatments. I suspect the level of conflict between physicians and the chaplaincy program is overplayed for the sake of good storytelling, though.
I'd guess that physicians at Beth Israel have mixed feelings that are not adequately represented by this article. For instance, I'm ecstatic this program exists to explore and support the spiritual needs of patients from a unique perspective, ambivalent about the method of self-disclosure that the chaplain proposes in the case of the patient with lung cancer, and a little concerned that someone might recommend seeing an herbalist for poorly controlled diabetes. (The article only infers what the chaplain might be suggesting, and I'd like to hear more about how he thinks a referral to this clinic might support patient adherence.) I'd guess many physicians would respond to this type of program with indifference. What do you think?
The tension described in the article is a familiar one to palliative care providers. Even within the profession of medicine, philosophies and approaches of providers may conflict. One of the main challenges for palliative care providers is to champion the principles of our profession while at the same time helping other providers to see that those principles are not always in conflict with other important principles of medicine. There is a similar struggle described in this article.
Regarding self-disclosure, I'm certainly willing to entertain the psychologist's proposition that it may be okay for chaplains to self-disclose, realizing that there are risks of doing this (for example, the risk of transforming the encounter into a self-therapy session that detracts from the patient's therapy). Pallimed covered physician self-disclosure in 2007. I am curious to hear from chaplains of any denomination about the topic of self-disclosure, and wonder if there is something in particular about the Buddhist mindset that makes self-disclosure less risky and more rewarding for the patient. The author of this article seems suggests that the chaplain who wishes to apply this method "operates under different rules," but it's not described how this relates to Buddhism per se.
While the program is a general chaplaincy program not strictly focused on a palliative care population, it appears to have the support of at least one member of the palliative care team:
Supporters of the Zen chaplains program say the monks' presence brings a calming influence to the often frenetic hospital floors, and that patients, for the most part, are open to them. "I think a lot of it has to do with the fact that a lot of our patients don't really know what a Buddhist monk does," said Terry Altilio, a social worker in Beth Israel's palliative-care department, which focuses on relieving suffering of seriously ill patients. "For a lot of patients, there's a curiosity and an openness you don't necessarily see with rabbis, priests, etc."This certainly rings a cord with my experience. Our team has a "spiritual adviser" rather than a chaplain, which does seem to help some suspicious patients keep an open mind about her role in their care (a role that is from a non-denominational, non-proselytizing stance). Speaking of non-Buddhist chaplains, some will take issue (rightfully) with the portrayal of "typical" hospital chaplains as somewhat feckless when it comes to difficult issues such as confronting death. As with any discipline, you'll find that some chaplains are more comfortable with these topics than others.
Lastly, picture #7 associated with the article made me dream about having a scalp massage each day at about noon (and q 3 hours prn afterwards).
Saturday, June 20, 2009 by Lyle Fettig ·
1) The first article discusses an approach to families who "expect miracles" in patients with very poor prognoses in the ICU. The author attempts to juggle the need to support surrogates' spiritual and emotional needs (as well as their substituted judgment) with the physician's obligation to avoid non-beneficial treatments when possible.
After a case presentation of an elderly woman who has multisystem organ failure, the author establishes a rudimentary differential diagnosis for the circumstance where a family brings up the possibility of a miracle. The differential listed includes:
- Hope/faith (trying to maintain a positive attitude in the face of an admittedly poor prognosis).
- Denial (due to lack of understanding about prognosis and/or reaching a different conclusion than the health care team about prognosis).
- Let's further parse out the "reaching a different conclusion about prognosis" etiology: This could be related to past family experience where the patient or another loved one made a seemingly miraculous recovery, but could also be related to mistrust of the health care team.
- A mechanism of control for family in the face of anger, disappointment, or frustration over some aspect of care.
The initial inclination for many practitioners is to tackle the miracle statement on an intellectual level, refuting the possibility of a miracle. The author correctly recommends clinicians avoid this approach. As he states, this approach will only alienate families. Why? Besides being a generally adversarial approach, it does not deal with the emotions underpinning the miracle statement. Families expressing hope for miracles in dire circumstances are not making an intellectual argument to begin with. The author gives some good suggestions for responding to miracle statements. His recommendations include (with some examples and comments from me):
- Ask family what a miracle means to them (i.e. what it might look like).
- Emphasize non-abandonment (which speaks to yet another item in the differential--fear of abandonment if goals of care are shifted towards comfort).
- Reframe the manifestation of miracles (i.e."miracles come in all shapes and sizes"). Better yet, try to have the family reframe the manifestation of miracles (e.g. "While we all hope for the miracle of recovery, are there other miracles you hope for or have already witnessed?)
- Suggest that if a miracle occurs, the physicians will do nothing to prevent it. (Perhaps it's better to phrase this in a more positive light and combine it with the statement of non-abandonment, such as "We will continue to monitor your loved one very closely and reevaluate his situation on a regular basis. Should a miracle occur, we will certainly embrace it and see where it takes us." For example, reassuring a family member if a loved one miraculously "woke up" after a severe anoxic brain injury, the medical team would
certainly entertain changing the code status back to full code.)
- Cite professional obligations to honor the patient's preference, or when that preference isn't clear, to act in the patient's best interest.
The article acknowledges some of these scenarios will lead to an impasse in decision-making. The suggestions provided should help to avoid this, but sometimes it's inevitable. A tincture of time can be helpful, too.
2) The second article is a general review of spirituality and religion in clinical care by Dr. Dan Sulmasy. It also addresses the issue of miracles both directly and tangentially:
Scientific medicine made it possible to reconcile belief in God as healer with the practice of medicine by physicians through an understanding of God as the inspiration and source for the physician's knowledge, and as the Creator of the world's healing resources, such as medicinal herbs (Sirach [Ben Sira] 38:1-15).
The rest of the second article is a decent review of the general topic of religion and spirituality. It includes an eloquent description of the difference between religion and spirituality:
I define spirituality as the ways in which a person habitually conducts his or her life in relationship to the question of transcendence. A religion, by contrast, is a set of beliefs, texts, rituals, and other practices that a particular community shares regarding its relationship with the transcendent. Spirituality is thus simultaneously a broader concept than religion and a narrower concept than religion. It is broader in the sense that all religious and even nonreligious persons confront the question of transcendence, and so the term is compatible with all forms of religious belief and even the rejection of religion. Spirituality is narrower than religion, however, in the sense that, because only persons can engage questions of transcendence, each relationship with the transcendent will always be unique and spirituality ultimately personal. Even within a given religion, there will be as many spiritualities as there are individuals.
by Lyle Fettig ·
I tried writing this post ten different ways, but I just could not get the introduction to sound right. So I'll just say it now: I am taking a two month sabbatical from Pallimed. I have no plans to quit the blog, but a wonderful opportunity came along that will consume a lot of my time over the next few months and I didn't want to 'phone it in' here. With Lyle, Drew and Tom writing you shouldn't notice a big change in the posts.
It was a hard decision to make, but between my paying job at Kansas City Hospice and my family and this blog, taking a break from Pallimed was the obvious decision.
If you are curious what I am up to it may not be hard to guess, especially with all the talking about social media I have done in the last few months. I decided to start a social media marketing consulting business called KLX Media. It's just a side project, but I want to start it off right. Thanks for all your comments on my posts over the last few years. I hope to come back fresh in a few months with a lot of great stuff to write about.
by Christian Sinclair ·
Tuesday, June 16, 2009
The National Alliance for Hospice Access issued a press release and data analysis regarding appropriate access to hospice. This is a significant issue for members of the NAHA because they are supporting reform to the current Aggregate Medicare Hospice Cap in addition to other reforms. The NAHA has voiced displeasure with lack of support from the NHPCO on NAHA positions. A more detailed comparison of the NAHA report to the NHPCO report may show some differences some may find compelling to change their mind and support the NAHA Cap Reform position.
Image by Daniele Sartori via Flickr
The main points from the NAHA data analysis include:
- 4 out of 10 hospice patients got no more than 10 days of care
- Only 16% of hospice patients get 60 to 180 hospice days, the range that improves quality and costs
- Minority access to hospice care trails access for whites by 25%
The poll on views towards the hospice cap last week while non-scientific leaned heavily towards cap reform. Much more than I ever expected given what I have heard in conversations from peers. 214 people voted (you could vote more than once - a significant problem with the poll structure) 13 people thought the cap was fine as it is. 25 wanted to know more about it and a whopping 176 thought it should be reformed. The reason I don't think this poll was accurate is because of people I have talked to at national palliative care meetings the number is more like 3:1 in favor of leaving it be. Also of the 4,000+ hospices, the majority of them are not members of NAHA.
So what that leaves me with is the opinion that we need to have some more open discussions about what the hospice cap problem is, who is affected and what should be done about if anything. If there are enough people discussing this issue in the comments, we will dedicate some more time to the hospice cap and maybe invite representatives of the major hospice organizations to have a roundtable discussion on the subject here on neutral ground at Pallimed.
So if you want it, make some noise. It sure worked for the FDA - morphine issue.
Tuesday, June 16, 2009 by Christian Sinclair ·
Image by .m.e.c. via FlickrFor those of you who neither live in Chicago nor devour columns by film critics you may have missed that Roger Ebert went off the air after complications from thyroid cancer surgery left him unable to speak a few years ago. He has still been quite creative and continues to write his syndicated column hosted by the Chicago Sun-Times.
He also has been blogging since April 2008 and just last month he published a fascinating piece about his reflections on his own mortality. The article is filled with many references to various poets, authors and painters, but only one documentary curiously. The title of the piece references the famous poem by Dylan Thomas, "Do Not Go Gentle Into That Good Night." He starts boldly with his lack of concern about what happens after death based on an Epicurean philosophy.
I know it is coming, and I do not fear it, because I believe there is nothing on the other side of death to fear. I hope to be spared as much pain as possible on the approach path. I was perfectly content before I was born, and I think of death as the same state. What I am grateful for is the gift of intelligence, and for life, love, wonder, and laughter.Some of the other interesting passages (but really go read it in full):
I have no quarrel with what anyone else subscribes to; everyone deals with these things in his own way, and I have no truths to impart.It would be nice if we had more open discussions about our own mortality. You will hear that all the time from any hospice or palliative care professional. I think this piece is also notable for a positive reflection on death from an atheist/agnostic perspective, which I have heard some hospice staff at times wonder aloud how one would approach death peacefully. Regardless of your religious or philosophical beliefs Roger Ebert demonstrates a mature, wise approach to his own mortality and I think it is something we could all learn from.
What I expect will most probably happen is that my body will fail, my mind will cease to function, and that will be that. My genes will not live on, because I have had no children. Perhaps I have been infertile. If I discover that somewhere along the way I conceived a child, let that child step forward and he or she will behold a happy man. Through my wife, I have had stepchildren and grandchildren, and I love them unconditionally, which is the only kind of love worth bothering with.
In a moment or a few years, maybe several, I will encounter what Henry James called, on his deathbed, "the Distinguished Thing." I may not be conscious of the moment of passing. I have already been declared dead. It wasn't so bad.
Take a read of the 500+comments as well.
Read this take on Ebert's post to see how it inspired others to reflect on their mortality.
Just because I wanted to here are all the artists mentioned in the post. (Almost a Pallimed: Arts & Humanities post by itself):
Edgar Allen Poe, Dylan Thomas, Walt Whitman, Vincent Van Gogh, Albert Camus, Thomas Wolfe, Cormac McCarthy, William Shakespeare, Saul Bellow, Brendan Behan, Henry James, Herge, e.e. cummings, Matthew Arnold, WB Yeats, Theodore Roethke, and DH Lawrence.
by Christian Sinclair ·
Sunday, June 14, 2009
Image by cafourek via FlickrWith all this discussion about health care reform, there have been a few bills proposed lately and I am going to cover a few of them here in very little detail. I would invite anyone who knows a lot more about these to write a personal (not canned) post and Drew and I will consider it for publication here. Email me at ctsinclair a.t. gmail dot c0m. More commentary on all these bills at the end of the post.
S.B. 1150 Advance Planning and Compassionate Care Act of 2009 by Sen. John Rockefeller [D, WV], Sen. Thomas Carper [D, DE], Sen. Susan Collins [R, ME], Sen. Herbert Kohl [D, WI], Sen. Debbie Ann Stabenow [D, MI], Sen. Ron Wyden [D, OR]
Key Objective of the legislation include:
1. Workforce (physician and nurse practitioner) adequacy and loan forgiveness, National Service Corps, curricular changes, and GME dollars (cap exemption) necessary to assure access to quality palliative care for all Americans;(via CAPC - more info here on how to support this bill - Hurry Deadline June 19th)
2. Development of provider reimbursement for conversations about goals of care, and in particular support for completion of orders for life sustaining treatment in appropriate patient populations (POLST);
3. Assuring access to concurrent curative and hospice care for children;
4. Incentives (payment, NQF quality measures compliance) for hospital and nursing home delivery of quality palliative care;
5. Establishment of a National Center on Palliative Care within the NIH as a mechanism to assure adequate attention to the evidence necessary to deliver highest quality of care; and
6. Conduct of an ongoing National Mortality Followback Survey to ensure a process of continuous improvement in the quality of care we deliver to this most vulnerable and needy of patient populations.
FDA Opioid Risk Evaluation and Mitigation Strategies Feedback (Deadline June 30th)
The FDA has an open comment period regarding future guidelines and restrictions on opioid prescribing which obviously could greatly affect palliative care and hospice practices. CAPC has put together some great talking points.
S.B.1251, the Senior Navigation and Planning Act of 2009 by Senator Mark Warner (VA)
Key objectives of the legislation include:
* Expanding Medicare's hospice benefits. A "transitional care" benefit would be available for terminally ill people expected to die within 18 months. Currently, Medicare covers hospice for people with a life expectancy of six months or less.
* Providing better education on living wills, counseling for dying patients and respite care for their families through that benefit.
* Requiring doctors, beginning in 2014, to offer certain Medicare patients, such as those with end-stage cancer, renal disease and congestive heart failure, information about advance directives and other planning tools. Doctors who failed to provide the information would not receive Medicare reimbursements.
(via Thaddeus Pope - Medical Futility Blog)
HR 2705: Advance Directives Incentive Act by Rep Jim McDermott [WA]
Details are minimal but Thaddeus Pope has this brief summary: Basically, it purports to amend the Internal Revenue Code to allow a refundable credit for advance directives. Unfortunately, it appears to likely to be be no more successful than the PSDA. First, the “qualified expenses” are limited to legal expenses. But presently, legal expenses are not a significant obstacle to the completion of advance directives. No attorney and usually not even a notary is required to complete an advance directive.
(via Thaddeus Pope at the Medical Futility Blog)
Not to mention the NHPCO lawsuit against CMS, the 2010 Wage Index issue, the NAHA and the Cap Reform. We need a simple site that tracks where all these things are. I am starting to get really confused with all these measures. Does anyone want to help organize the information coming from all of these sources regardless of which organization supports which bill? We could act as a non-partisan repository if someone else was up to it.
Also I see all these formalized efforts by NHPCO, CAPC, NAHA and others being potentially weaker because there is not a way for people to show they wrote letters to get a bandwagon like effect or a merit badge phenomenon. Could social media tools like Facebook, Twitter or blogs be a way to say "I wrote my letter...have you?" By the way I haven't written to support or oppose any of these measures so I guess I should stop writing this post and maybe do some grass roots advocacy. Feel free to post here if you have.
Sunday, June 14, 2009 by Christian Sinclair ·
I walked into the room and I saw a ninety year old, 100 pound guy who glowed yellow. He looked skeletal. His skin was paper thin, like cellophane wrapped around a chicken breast. He was affable enough. He knew where he was. He said his stomach had been hurting him for months. He'd lost close to fifty pounds since Christmas. He lived alone in an assisted living facility. He had a son in Alabama, but that was it...The next day he came in to find several consultants notified and a full medical workup beginning. Read the rest of his well written post to hear what he did to make this a better situation. Leave some comments in his blog post too, after all we need to support surgeons and other doctors who see these situations.
...His Ca19-9 was over 20,000. A CT scan had been done at 3AM but there wasn't a read on it yet. I looked at it myself and easily identified a giant mid body pancreatic mass with multiple liver mets. I wrote a note about the findings and recommended a hospice consult.
by Christian Sinclair ·
Thursday, June 11, 2009
If you clicked through to Pallimed from the recent New York Times column on "Medicine in the Age of Twitter" welcome to Pallimed.
This is a blog discussing news and research about palliative medicine and hospice and while some of the discussions are aimed at the medical professionals in the field we openly invite any patients or families to ask questions and leave comments. Our goal here is to have an open forum about some of the difficult issues in medicine regarding pain control, making medical decisions in the face of life-threatening illness, how to be better communicators with our patients and families, and many other topics.
You can see some of our major topics by clicking on any of the labels in the label cloud in the left hand column. You may find our companion blogs "Arts & Humanities" and "Case Conferences" interesting as well so please click on them on the top.
We have five contributors here:
Drew Rosielle, MD (Editor/Founder)
Christian Sinclair, MD, FAAHPM @ctsinclair on Twitter
Thomas Quinn, APRN, CHPN
Lyle Fettig, MD @lyfe20 on Twitter
Amber Wollesen, MD
Amy Clarkson, MD
If you have any questions or experiences with hospice or palliative care or medicine and social media please leave a comment and we'll start a conversation. If you are a doctor, nurse or generally involved in health care and want to talk more about how to use social media wisely feel free to email me at ctsinclair [at] gmaill [dot] com. (And I will tell you why I am not afraid to give out my personal email and other medical staff should not be either)
Thursday, June 11, 2009 by Christian Sinclair ·
Wednesday, June 10, 2009
Two related articles on surrogate decision making.
Research on Aging has a study about older adults' understanding of their spouses' end of life preferences. The data come from the Wisconsin Longitudinal Study - a large, decades long study of many thousands of people who graduated from Wisconsin high schools in 1957 (nearly all participants are white). This study involves ~2700 married couple, all approximately 65 years old, who were surveyed in 2004 and were asked, among other things, questions about EOL treatment preferences: the scenarios given were basically 'you're dying and in severe constant pain - would you/spouse want to continue/not all life-prolonging treatments?' & 'you have limited ability to speak/walk/recognize others - would you/spouse want to continue/or not life-prolonging treatments?' Respondents said what they'd want and what they thought their spouse would want.
Most people (80% range for pain, 90% range for cognitive impairment) said 'No' to life prolonging treatments in both scenarios for both themselves and their spouses and there was good concordance (in the 80% range). About a third of participants had named a health care power of attorney; and about half said they had discussed preferences with their POA. There weren't any real gender differences and respondents reporting that they had spoken about their preferences with their spouse weren't any better predictors than those that hadn't.
A few thoughts about this. The concordance rates here are significantly higher than prior research into this (this is me speaking from memory here - my general impression over the years from following similar research is that surrogates/spouses' predictions are very accurate), however pretty much everyone here was saying 'no thanks' to these scenarios which make this difficult to interpret. This represents further research showing that having a conversation with a loved one (or at least reporting you've had a conversation) does not improve accuracy in predicting what that loved one would say in these EOL scenarios. Finally, what gives me pause about this whole thing is wondering how helpful the scenarios actually are, particularly the first one. (The second scenario essentially describes severe dementia and most Americans seem to say 'keep me comfortable' when severe dementia is described to them, which is not to say that is what happens by any means.) The first scenario describes a thankfully rare situation, and I can't remember the last time, when I sat with a surrogate and said 'your choices are maintaining your loved one is a state of permanent severe pain or keeping them comfortable.' This is for a lot of reasons of course, but most of the conversations/scenarios are much more ambiguous and aren't 'either/or' Comfort+Death-sooner vs. Agony+Death-a-little-later scenarios. And I'm glad they're not. But the fact that most people don't choose Agony+Death-a-little-later for their spouses (who agree!) is not particularly telling about the accuracy of surrogate decision-making.
Of course the Real Big Question here is if so many of us (by us I guess I mean Americans) want no life-prolonging treatments in the setting of advanced dementia why are so many of us getting them?
Journal of Aging and Health has a qualitative study on how surrogate decision makers of patients with dementia arrived at their knowledge of patients' EOL wishes. The study involves interviews with 34 surrogates (76% white, 79% female, 38% children, 35% spouses) of nursing home residents with advanced dementia, and involves asking them about EOL decisions, what the surrogates base that on, etc. Most of the paper is a thematic, narrative description of what these surrogates said about conversations they had, how/why the patient filled out an advance directive, what prompted having a discussion about EOL care with the surrogate (if ever), what the surrogate is basing their decisions on, etc. I basically found it an interesting read - what these people said about these experiences - it's kind of like seeing your (work-) life laid out before you.
A couple interesting items from the paper.... First is a list of how the surrogates described what their loved ones said to them about 'extraordinary measures' (this the language the surrogates used):
Not on a machine just to stay aliveI initially thought 'life suspension' was kind of quaint, but reflecting on it further it doesn't seem inappropriate at all to the situation.
No life suspension
No keeping alive with machines
Not prolong this life
If we ever got terminal, don’t hook us up to anything
We don’t want life extended by artificial means
No advance life support
“I wouldn’t want to be kept alive by a machine”
Not on any type of machinery to keep her alive; “I don’t want to be kept alive artificially”
She wouldn’t want to be hooked up to any system to keep her
Absolutely no extra activities to keep him alive
No life support
If it’s her time she wants to go. “Don’t keep me here. Don’t hook me up.”
Didn’t want to be on no support thing, like something to keep her living
Didn’t want to be held for 5 years on artificial nourishment
The second speaks for itself, and was a reminder to me of just how difficult it can be at times for family members who are told some variation of You need to make the decision s/he would make if he could. Some people take that instruction seriously, which doesn't make it any easier, and I've seen it cause more confusion than clarity on numerous occasions. Patients don't know what they want half the time: they want 'to live' (who doesn't?) but don't want unnecessarily burdensome, painful, displacing, unhelpful medical care when they're dying (who doesn't?) - the problem is figuring out what exactly that means. I have easily had a dozen situations in the last year in which a loving family member, struggling with a decision, told me some variation of 'Mom told me she never wanted to go a hospital and that I should never give up on her no matter what.'
Interviewer: So he never, ever mentioned what kinds of medical procedures he would want if he became very ill?
Surrogate: Well, once in a while he would say something. He’s not consistent.
Sometimes he says, “Yeah, I want them to do everything.” And then, if he
sees something on TV, he’ll say, “I don’t want that.” And then he’ll go back,
“Yeah, they should try to save you.” So, they just put the whole burden on us
to figure it out.
Interviewer: Okay, so there was no informal planning or formal planning at all.
Surrogate: Uh-uh [negative].
Interviewer: And what is your understanding of what your father wants? How
did you come to some understanding that helped you decide his view?
Surrogate: Well, I’m still in a quandary over that, to tell you the truth.
Wednesday, June 10, 2009 by Drew Rosielle MD ·
BMJ has published a randomized controlled trial of a video-based decision support tool for advance care planning in dementia (related to this trial we blogged on a couple years ago; see also here). The video used is available in the free-full-text version on the BMJ website. This study invovled older patients who were randomized to a narrative description of advanced dementia vs. a video depicting a patient with AD, and asking subjects what sort of care they'd want. This is similar to the prior study but this study uses a separate control group (the prior one compared subjects' responses before and after seeing the video). As in the prior study, after seeing the video, the vast majority of subjects reported they'd prefer comfort-only measures and no life-prolonging treatments (86%, vs 64% in the written group). The video group's knowledge of dementia was better afterwards, and their treatment preferences were more durable (didn't change over time) compared with the written group.
This research is quite compelling: very simple and elegant in its design and execution, with compelling results. I am curious as to how it will be received in the general community (I guess I mean in primary care clinics where presumably this ACP should be happening) and if it will change anything, or if there are plans to bring this sort of ACP to the masses (e.g. public education campaigns, etc.). I don't do a lot of ACP for dementia (I get consulted on patients after they have dementia and family members are struggling with decisions) but do do a lot of 'ACP' about, for instance, CPR and it looks like Angelo Volandes (the doc primarily behind most of this research) is working on that very thing: http://www.acpdecisions.com/acpdecisions/Videos.html. I'm very much looking forward to the videos and what the research shows about their impact.
The same BMJ issue has another part in the series I mentioned before on prognostic research: this one is on validating prognostic models, which is a relevant topic for Pallimed readers as we frequently discuss research on prognostic models and wonder how one can really judge their clinical relevance.
There's also a fascinating speculative article for pharmacology wonks out there and the generally curious about how psychiatric drugs work. I do not know if what the authors propose is 'correct' however it's always good to have one's paradigm's challenged. The core of their argument is as such:
An alternative, drug centred model of drug action, stresses that psychiatric drugs are, first and foremost, psychoactive drugs. They induce complex, varied, often unpredictable physical and mental states that patients typically experience as global, rather than distinct therapeutic effects and side effects. Drugs may be useful because some altered states can suppress the manifestations of certain mental disorders. The disease centred model of drug action developed in the 1950s and 1960s and replaced a drug centred understanding of how psychiatric drugs worked. For example, the early investigators of neuroleptic or antipsychotic drugs suggested that they worked by inducing a neurological syndrome consisting of physical restriction and mental symptoms such as cognitive slowing, apathy, and emotional flattening, which resembled Parkinson’s disease. These effects also reduced the intensity of psychotic symptoms. Thus, extrapyramidal effects, and their conjoined mental effects, were not regarded as side effects but as the mechanism by which the drugs produced their intended outcome.3)
Lancet Oncology has a wonkish discussion of 'palliative sedation.' It's a somewhat searching, philosophical (literally: discusses personhood in the context of Descartes, Locke, Kant, and others), and meandering walk through the ethical controversies surrounding PS (they call it 'deep and continuous palliative sedation' when referring to the practice of deliberately pharmacologically inducing a coma with the intention of maintaining a patient in it until death in order to relieve intractable suffering). A lot of it focuses on the question of if inducing a coma extinguishes thought, does it therefore extinguish self-hood/person-hood, and if there's no intention of lightening the coma, is not one then 'killing' a person, and so is PS just a form of (or philosophically/morally equivalent to) euthanasia? Yes, I said it's wonkish, and while I don't think these Big Ideas are meaningless (and frankly enjoy thinking about them), and probably become more relevant the further PS gets away from a strategy to treat intractable somatic symptoms in otherwise dying patients, I also struggle with where the 'fancy' ideas get us.
by Drew Rosielle MD ·
Sunday, June 7, 2009
Neurology has a fascinating study about the impact of delirium on cognitive decline in patients with dementia.
The patients, all with dementia, come from a single institution's large memory clinic, and were followed at regular intervals longitudinally. They essentially compared the rate/trajectory of cognitive decline in patients without incident episodes of delirium (~3oo patients) with those who with an episode of delirium (~70 patients).
(Note: they identified patients with delirium based on hospital chart review - it's unclear exactly how but it looks like it includes looking for documentation of acute alternations in mental status in the chart. This strikes me as a way of underestimating delirium as I often see it missed (diagnostically) and missed/ignored in charts. When I was a fellow I did a chart review for a project and remember seeing all these progress notes with physical exam documentations "A&O X3" pretty much every day. Concurrent with that the speech therapist would be leaving daily notes: 'Tried to do bedside swallow eval; patient lethargic and unable to cooperate.' This could go on for days. Anyway, one hopes they included speech path notes in their chart review.)
After adjusting for age, sex, educational level, dementia severity rating score, duration of dementia symptoms before diagnosis, family history of dementia, and number of comorbid medical diagnoses they found that those who had delirium had a more rapid rate of cognitive decline after delirium compared with those who didn't. In fact, the rate of decline for those without delirium was flat across the assessments; for those with delirium it sharpened (worsened) after the episode.
All this is based on a dementia severity rating score that I'm not familiar with and I can't really comment on the magnitude of the change, but it was statistically significant. The two groups' rates of decline (after controlling for the above factors) was similar prior to the interval in which the delirium occurred suggesting that in fact the episode of delirium was a disease modifying event, for the worst (the alternative explanation is that whatever caused the delirium was the disease modifying event). The authors give this ball-park estimation of the effect of an episode of delirium:
From a clinical standpoint, this study suggests that over 12 months, patients with AD who become delirious experience the equivalent of an 18-month decline compared to those who do not experience delirium.This so far has been the year of quantifying just how significantly delirium increases morbidity and mortality in older and particularly demented patients, and this paper adds to the mix.
A few thoughts & questions.... When I was taught about delirium in medical school and residency my sense was that it was this self-limited event/syndrome that occurred generally in the setting of acute medical illness/stressors (including drug toxicities) and then just kinda gets better once the problem causing the delirium is fixed/resolved/removed. I think I had some sense that it was a poor prognostic marker for those with dementia as well. However, it appears it can also be not just a prognostic marker but a disease modifying event as well (one that actively worsens prognosis and is not just an epiphenomenon of a poor prognosis) and can persist long term/indefinitely at times. Is this me just gaining some wisdom or is this an emerging concept that is coming out with stronger and stronger research backing the last several years?
In addition, if hospital delirium is so bad, why is its prevention and treatment so poorly studied? Prevention has some decent research base, treatment really has very little besides a few key articles. If the above is true one could argue that preventing a single episode of delirium is likely going to help someone as much as years of donezepil, yet why is delirium essentially being treated as an orphan syndrome? Cynical answer: drug companies aren't interested. Non-cynical answer: people are only just beginning to realize the long-term morbidity it causes.
Sunday, June 7, 2009 by Drew Rosielle MD ·
Annals of Oncology has an article about the use of chemotherapy at the end of life. It's a retrospective cohort study from a single cancer center in Australia, looking at all patients who had died (N=750; median age 67 years; 20% with lung cancer and the rest with a smattering of everything else) from incurable solid tumor malignancies between 2005 and 2007 (patients who died while receiving treatment with curative intent were excluded).
Only 4 and 10% of patients received chemotherapy during the last 2 and 4 weeks of life, respectively. This is significantly lower than recent US figures (which are in the 15-20% range for the last 2 weeks of life). Age, gender, country of origin, type of cancer did not predict receiving chemotherapy in the last month of life. However, treating oncologist did - there were distinct and significant differences between individual oncologists (rates ranged from 8% to 28%). There was a strong trend (not reaching statistical significance) for individual oncologist being a predictor of receiving chemo in the last 2 weeks of life as well.
Some caution here: this was a univariate analysis and it's possible that certain oncologists treated different types of cancers which lead to the differences. However, when they actually looked at if type of cancer predicted receiving late chemo it didn't which would suggest this is not the case at least with these data. (They anecdotally suggest in their comments as well that at this center all the oncologists treat all cancer types.)
This is a disturbing finding. The type of care you receive (including the circumstances of how you die) should ideally be determined by you/your values and what's medically available/reasonable - not by which doctor you happen to get assigned to. You wouldn't want to die in an ICU against your wishes just because of who your PCP happens to be and this isn't any different. There will always be variations in practice, style, approach, etc. - of course. A more than 3-fold difference however, again assuming these oncologists were seeing similar mixes of patients, is an indication that the type and quality of care was being determined by something other than patients and what's medically reasonable. Always, but in particular at life's end, the care patients receive should be 'about them' (for them, to meet their goals, etc.) and not 'about us' as doctors and what we are and aren't comfortable with. I'm not particularly aware of other studies which have shown this phenomenon (about individual docs) but they may be out there (please comment on them if you know of them). (In the Coping with Cancer Study, regional variations made a big difference for, perhaps, comprehensible reasons.)
They also mention this issue, which I guess is important in the Australia, too:
Another possible explanation for the continuation of chemotherapy at the end of life is that recommending a new course of chemotherapy to patients is often an easier option than discussing cessation of chemotherapy and transition to palliative care with them and their caregivers. It is ironic that in both the United States and Australia, oncologists receive financial reimbursement for chemotherapy delivery but little or no reimbursement for the time-consuming and emotionally difficult process of family conferences or end-of-life discussions.Even at the academic center I work at, in which there is no direct or really indirect financial incentive for my colleagues to prescribe chemotherapy, there is a distinct lack of compensation/incentive for talking with patients at length (I know because that's what I do and it's not very reimbursable). The sad thing is, in oncology and elsewhere, the vast majority of people want to do the right thing but we've created this system for ourselves which effectively punishes us for doing that as it means we see fewer patients in a day, or spend longer hours doing the right thing without any commensurate compensation.
by Drew Rosielle MD ·
Wednesday, June 3, 2009
A New York Times reporter writes about the experience of her sister's death and not pursuing an autopsy. She also reports on Dutch research of family members' experiences with autopsy (from Family Practice). Based on the details provided, the author's sister died after what sounds like an unfortunately precipitous infectious disease and multisystem organ failure. A week before she died, she had seen a doctor, was sent home, then returned to the hospital the following day critically ill. After the death, a nurse (not a physician ?!?) approached the author and another sister to discuss autopsy, which they declined. The author later regretted not pursuing an autopsy because she had unanswered questions about the cause of death. She states that initially, this decision was made because they had "had enough" and because "it wouldn't bring her back." (These seem to be the amongst the most common reasons cited when I discuss autopsies, along with, "I don't want to put him/her through that.") But then, she goes on to discuss further:
Another reason, I realized later, was a vague, underlying sense of distrust. We weren’t confident that the hospital could provide a thorough and competent autopsy, and even if it could, we didn’t trust the doctors to tell us the whole truth. It was an unfair judgment. But we were distraught.In other words, either a) the hospital's pathologists may be in cahoots with the potentially negligent treating physicians or b) hospitals with potentially negligent treating physicians may also have negligent pathologists (this is the "reverse halo effect" or "devil effect"). She writes about the missed opportunity to pursue independent review by an outside pathologist, and talks with a pathologist, Dr. William Manion, who does "private" autopsies. Dr. Manion does, fortunately, refute the hypothesis that a hospital's pathologists might "protect" the treating physician by giving a dishonest pathological evaluation.
On request, he'll also perform an independent review of medical records and autopsy results.
Which makes me wonder, since a nurse discussed the possibility of an autopsy with the author, did the author have much of a chance to discuss her sister's condition with the treating physicians or her primary care physician? Was there any chance for her to go back later and revisit unanswered or new questions weeks or months after the death?
Some clients hire him because they want to sue doctors, he said in an interview, but others are just looking for peace of mind. Some are upset because they feel doctors didn’t take the time to explain what happened. “A lot of times people just feel guilty themselves that their loved one died,” Dr. Manion said. “They blame themselves that they didn’t get them help sooner for an alcohol or drug problem, and I say, you can’t help an alcoholic or an addict. I try to explain to people, this isn’t your fault.”
Plenty has been published on the positive effects of good communication in the ICU. One of the most prominent studies was discussed here. Also, better communication has been associated with reduced malpractice claims. One might hypothesize that better communication leads to more appropriate use of autopsy and that both will help with the bereavement process. If true, the mechanism may be through providing families with answers to unanswered questions and reassurance but also offering the opportunity for a physician to provide bereavement support at the time of autopsy review. Could the autopsy thus reduce attempted lawsuits in some scenarios? (This might seem paradoxical to those that fear an autopsy might provide "ammunition" to families and attorneys.)
The Dutch study proposes that the best physician to review the autopsy with loved ones is the general practitioner/primary care physician, but they note that in the US, it is standard procedure for the pathologist to discuss with family. (I must confess that I did not know this.) Given the fragmented nature of our medical system and the fact that primary care itself is on life-support in this country, perhaps this division of labor is appropriate. However, it seems to me that one of the treating physicians might be in the best position to discuss autopsy results in most cases. What role should palliative care physicians play in discussing autopsy results? I would imagine there is variability depending on practice setting and local norms and would be curious to hear about the experience of others. While it's infrequent for my patients to receive autopsies, I would estimate that I've discussed results with families in about a third of those cases (amounting to 1-2 per year).
The Times has an associated question/answer section with two pathologists entitled, "Should You Have an Autopsy Done?" with several comments and questions from physicians.
(Image The Anatomy Lesson of Nicolaes Tulp, by Rembrandt courtesy of Wikipedia.)
Wednesday, June 3, 2009 by Lyle Fettig ·
Pain recently published a small cohort study that attempted to provide insight into the question, "Does cachexia decrease the absorption of transdermal fentanyl?" (Not to be confused with the question, "Is transdermal fentanyl less effective in cachectic patients? Read on.)
An urban legend exists (perpetuated by well-meaning hospice and palliative care providers) that fentanyl TD isn't as effective in patients with cachexia (and maybe should be avoided in that population). The absorption of fentanyl TD depends on skin permeability and local blood flow, and perhaps one or both are reduced in cachexia. The "state of the science," as far as I know, says that while this hypothesis may make sense physiologically, the question of reduced effectiveness remains unstudied.
This Finnish study recruited twenty patients with cancer pain, ten who had a normal weight (BMI average BMI 23 kg/m2) and ten who had cachexia (average BMI 16 kg/m2). Eight of the patients (five with normal weight and three with cachexia) were already using fentanyl TD. The other patients were converted from their previous opioid (morphine or oxycodone) to an equianalgesic dose of fentanyl TD. The two groups were similar in age, baseline skin temperature, sweating, and blood flow (all factors that may influence fentanyl pharmacokinetics). The cachectic group had a longer median duration of disease than the normal weight group (5.5 months vs. 2.5 months, respectively), skin fold thickness, and a higher fentanyl TD dose based on conversion from the other opioid or previous fentanyl needs (96 +/- 29 mcg per hour vs. 42 +/-10 mcg per hour).
The authors attribute the higher opioid dose in the cachectic group to greater pain associated with more advanced disease, but do also mention the possibility that of those who were on fentanyl beforehand, participants with cachexia may have required more because of absorption issues. Although the authors presumably had data that may have confirmed or denied this hypothesis (i.e. - the fentanyl TD doses of those already on it before the study) they do not present this data...I'm unsure why they didn't just exclude patients already on fentanyl.
Subjects were followed over the subsequent 72 hours. Plasma fentanyl concentrations were determined at baseline, 4 hours, 24 hours, 48 hours, and 72 hours and then were adjusted for dose. The authors found that at 48 and 72 hours, cachectic subjects had a significantly (based on SEM) lower dose adjusted plasma concentration of fentanyl but at earlier time intervals there we no statistically significant differences. The mean plasma concentration per dose (mcg/l/dose) was 0.014 vs. 0.023 at 48 hours and 0.012 vs. 0.024 at 72 hours in cachectic and normal weight subjects, respectively. When looking at the 95% confidence interval for these time intervals, though, there was some overlap between the plasma concentration per dose (mcg/l/dose) of normal weight patients and cachectic patients, so the difference really isn't significant although it is a very small sample of patients.
The authors report that the median time to maximum fentanyl concentration in subjects naive to fentanyl was 48 hours in cachectic patients compared to 24 hours in normal weight patients. Of course, this is a median, and one would need to do continuous sampling to really determine whether there is a difference between the two groups. Pain intensity as measured by visual analogue scale was comparable between groups and didn't change significantly from baseline to 72 hours. Fentanyl dose changes were not permitted over the 3 days, but patients could use short acting opioids for breakthrough pain. The amount of breakthrough pain medication needed was not reported.
The authors discuss the unpredictable relationship between opioid concentration and analgesia:
There seems to be no concentration-effect relationship for fentanyl or other strong opioids and lack of correlation between plasma fentanyl concentration and analgesia is evident in the present study and that of Solassol et al., where transdermal fentanyl administration resulted in a wide range of individual plasma fentanyl concentrations but provided adequate analgesia. The plasma opioid concentration is an unreliable reflector of opioid analgesia since the opioid analgesic effect is also influenced by factors such as the intensity of pain, opioid tolerance and the concentration of the opioid in the central nervous system after crossing the blood–brain barrier.But then go on to conclude:
The clinical implication of our study is that transdermal fentanyl is not the opioid of choice for cachectic cancer patients with pain. Poor transdermal absorption of fentanyl in these patients may result in inadequate analgesia despite an apparently large dose of opioid. Further research is needed to study the factors that lead to impaired skin permeability and poor fentanyl absorption in patients with cancer cachexia.These two quotes appear contradictory. If there is apparently no concentration-effect relationship for opioids and pain relief, then you can't conclude from this study (which looked at fentanyl concentrations closely, but not very closely at more appropriate outcomes such as VAS scores and breakthrough opioid needs) that fentanyl TD is a second-class opioid in cachectic patients. I'm okay with a conclusion that cachexia may impair fentanyl absorption, but not okay with concluding that fentanyl is not the opioid of choice for cachectic patients, at least on the basis of this study.
Now, before you conclude that I have a financial relationship with Janssen Pharmaceuticals, makers of Duragesic (I don't) or am just one of those that thinks fentanyl patches are a "slice of heaven," I'm firmly planted in the camp of those who think fentanyl patches should generally be reserved for patients who can't swallow or who have some other compelling reason. This is based more on issues related to interindividual variability of absorption (unrelated to weight), cost, and wanting to use a single opioid if possible (e.g. MSIR plus MSSR).
We'll wait for a study with larger cohorts of patients where the primary endpoints are related to effectiveness (e.g. VAS and breakthrough opioid needs) over a longer period of time. In the meantime, this study won't change my practice - in cachectic patients for whom I initiate fentanyl TD, I'll continue to use recommended conversions, make sure they have a good breakthrough opioid, and adjust the dose of the patch as necessary.
by Lyle Fettig ·
Palliative Care Grand Rounds is here again! (Must be the first Wednesday of the month.) Angela Morrow, RN is a blogger for About.com's Palliative care section. Head on over to the blog and check out some of the great links to the best of the palliative care blogosphere in the past month.
If you are a palliative care blogger and you want to host an upcoming session let me know! We still don't have a logo for the series so if there are any budding graphic designers out there willing to give it a try that would be great.
by Christian Sinclair ·